# PIPERACILLIN AND TAZOBACTAM
> **ANDA207146** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2017-03-17
## Drug
- **FDA Application Number:** ANDA207146
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PIPERACILLIN AND TAZOBACTAM
- **Generic name:** Piperacillin Sodium
- **Active ingredients:** PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** APOTEX
- **First approval:** 2017-03-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207146)
---
*AI Analytics · CC0 1.0*